09:30 – 12:30 (180’), Orche Ⅰ&Ⅱ
13:30 – 16:30 (180’), Orche Ⅰ
14:15 – 15:15 (60’), Orche Ⅱ
15:30 – 18:00 (150’), Orche Ⅱ
This session reviews the latest FDA HFE requirements and contrasts them with IEC 62366‑1–based approaches.
It also introduces strategies for responding to usability evaluation findings through real supplementary review cases.
| Time | Title | Speaker |
|---|---|---|
| 15:30 – 15:35 (05’) | Opening Remarks | KHIDI |
| 15:35 – 17:45 (130’) | Human factors considerations for US FDA medical device commercialization | Korey Johnson Bold Insight CEO |
| 17:45 – 18:00 (15’) | Q&A |
You can click on each speaker to view their Professional Experience and Abstract.

Bold Insight
CEO
He is an expert with more than 20 years of experience in medical device human factors and usability engineering. As the President of Bold Insight, he leads human factors research and evaluation for medical devices. He has been an active member of the AAMI Human Factors Engineering Committee and recently contributed to the revision of ANSI/AAMI HE75:2025.
This presentation reviews the core requirements of FDA human factors and usability evaluation for medical devices, highlighting key considerations through real global case examples. It will cover formative evaluations, human factors validation, use related risks and mitigation strategies, and practical issues companies must address to meet FDA expectations during the review process.